The pristine samples from asteroid Ryugu returned by the Hayabusa2 mission on December 6, 2020, have been vital to improving ...

Kalshi raises $185M at $2B valuation, signaling prediction market maturity and crypto sector growth amid regulatory challenges.

Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

Harvard's pivot to privately funded research could reduce the burden on taxpayers and lead to more scientific breakthroughs.

A new DEX called GTE has received funding support to beat the existing CEXs and DEXs using its CLOB model. Can it overcome ...

For MBS investors, the ability to link data to specific loans and securities offers more precise analysis, alongside other advances in data and analytics ...

GTE raised $15M in Series A funding led by Paradigm, aiming to become the fastest decentralized exchange and rival major ...

Kalshi founder Tarek Mansour announced on Wednesday that the online trading company that offers sports outcome contracts ...

White House reacts after intel assessment contradicts Trump on Iran strikes What to Do with Pennies: Smart Uses for the Coins ...

Paradigm Biopharmaceuticals (ASX:PAR) has acquired the exclusive global rights to develop – and, of course, commercialise – a ...

Paradigm has filed an amicus brief arguing the jury in the case against Tornado Cash co-founder Roman Storm needs clarity on ...